Transthyretin forms amyloid fibrils at physiological pH with ultrasonication

References

• Sousa M M, Saraiva M J. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signalling. Prog Neurobiol 2003; 71: 385–400
   PubMed Web of Science ®Google Scholar
• Yang M, Lei M, Bruschweiler R, Huo S. Initial conformational changes of human transthyretin under partially denaturing conditions. Biophys J 2005; 89: 433–443
   PubMed Web of Science ®Google Scholar
• Hammarström P, Jiang X, Hurshman A R, Powers E T, Kelly J W. Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc Natl Acad Sci USA 2002; 99: 16427–16432
   PubMed Web of Science ®Google Scholar
• Jiang X, Smith C S, Petrassi H M, Hammarström P, White J T, Sacchettini J C, Kelly J W. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry 2001; 40: 11442–11452
   PubMed Web of Science ®Google Scholar
• Lai Z, Colon W, Kelly J W. The acid-mediated denaturation pathway of transthyretin yields a conformational inter mediate that can self-assemble into amyloid. Biochemistry 1996; 35: 6470–6482
   PubMed Web of Science ®Google Scholar
• Gustavsson A, Jahr H, Jacobson D R, Sletten K, Westermark P. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Lab Invest 1995; 73: 703–708
   PubMed Web of Science ®Google Scholar
• Stathopulos P B, Scholz G A, Hwang Y M, Rumfeldt J A, Lepock J R, Meiering E M. Sonication of proteins causes formation of aggregates that resemble amyloid. Protein Sci 2004; 13: 3017–3027
   PubMed Web of Science ®Google Scholar
• Ando Y, Yamashita T, Nakamura M, Tanaka Y, Hashimoto M, Tashima K, Suhr O, Uemura Y, Obayashi K, Terazaki H, Suga M, Uchino M, Ando M. Down regulation of a harmful variant protein by replacement of its normal protein. Biochim Biophys Acta 1997; 1362: 39–46
   PubMed Web of Science ®Google Scholar
• Bonifacio M J, Sakaki Y, Saraiva M J. ‘In vitro’ amyloid fibril formation from transthyretin: the influence of ions and the amyloidogenicity of TTR variants. Biochim Biophys Acta 1996; 1316: 35–42
   PubMedGoogle Scholar
• Glenner G G, Eanes E D, Bladen H A, Linke R P, Termine J D. Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 1974; 22: 1141–1158
   PubMed Web of Science ®Google Scholar
• Nielsen E H, Nybo M, Svehag S E. Electron microscopy of prefibrillar structures and amyloid fibrils. Methods Enzymol 1999; 309: 491–496
   PubMedGoogle Scholar
• Yamamoto S, Hasegawa K, Yamaguchi I, Tsutsumi S, Kardos J, Goto Y, Gejo F, Naiki H. Low concentrations of sodium dodecyl sulfate induce the extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. Biochemistry 2004; 43: 11075–11082
   PubMed Web of Science ®Google Scholar
• Terzi E, Hölzemann G, Seelig J. Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes. Biochemistry 1997; 36: 14845–14852
   PubMed Web of Science ®Google Scholar
• Morillas M, Swietnicki W, Gambetti P, Surewicz W K. Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem 1999; 274: 36859–36865
   PubMed Web of Science ®Google Scholar
• Hatters D M, Lawrence L J, Howlett G J. Sub-micellar phospholipid accelerates amyloid formation by apolipoprotein C-II. FEBS Lett 2001; 494: 220–224
   PubMed Web of Science ®Google Scholar
• Lashuel H A, Lai Z, Kelly J W. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation. Biochemistry 1998; 37: 17851–17864
   PubMed Web of Science ®Google Scholar
• Ohhashi Y, Kihara M, Naiki H, Goto Y. Ultrasonication-induced amyloid fibril formation of beta2-microglobulin. J Biol Chem 2005; 280: 32843–32848
   PubMed Web of Science ®Google Scholar
• Satheeshkumar K S, Jayakumar R. Sonication induced sheet formation at the air-water interface. Chem Commun 2002; 19: 2244–2245
   Google Scholar
• Gales L, Saraiva M J, Damas A M. Structural basis for the protective role of sulfite against transthyretin amyloid formation. Biochim Biophys Acta 2007; 1774: 59–64
   PubMedGoogle Scholar
• Ando Y, Nyhlin N, Suhr O, Holmgren G, Uchida K, el Sahly M, Yamashita T, Terasaki H, Nakamura M, Uchino M, Ando M. Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem Biophys Res Commun 1997; 232: 497–502
   PubMed Web of Science ®Google Scholar
• Saito S, Ando Y, Nakamura M, Ueda M, Kim J, Ishima Y, Akaike T, Otagiri M. Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis. Biochemistry 2005; 44: 11122–11129
   PubMed Web of Science ®Google Scholar
• Kingsbury J S, Theberge R, Karbassi J A, Lim A, Costello C E, Connors L H. Detailed structural analysis of amyloidogenic wild-type transthyretin using a novel purification strategy and mass spectrometry. Anal Chem 2007; 79: 1990–1998
   PubMed Web of Science ®Google Scholar
• Edmonds P D, Sancier K M. Evidence for free radical production by ultrasonic cavitation in biological media. Ultrasound Med Biol 1983; 9: 635–639
   PubMed Web of Science ®Google Scholar